Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**VX1 French grape seed extract** is a proprietary grape seed extract used in nutraceutical products rather than an approved pharmaceutical drug. It is marketed as a French grape seed extract enriched and standardized for low-molecular-weight oligomeric proanthocyanidins and other polyphenols, with positioning around antioxidant and vascular support, but there is no clearly established single molecular target or pharmaceutical mechanism of action comparable to a regulated drug. The available evidence and commercial context indicate it is an ingredient used in dietary supplement formulations such as Clinical OPC, not a distinct prescription medicine or investigational biotech asset.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VX1 French grape seed extract.